Delivery Order SPE2DB22D2007-SPE2DB25FJ3GD
- Not listed
- The Defense Logistics Agency awarded a $6,007.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tasigna 150 mg capsules (28-count). The contract, which represents a non-competitive set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency Troop Support Medical awarded a $22,498 delivery order to Amerisourcebergen Drug Corporation for 28 packages of Tasigna 150 mg capsules. The product will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a firm fixed price contract running from September 1st through September 25th, 2023. Tasigna is a prescription medication used to treat chronic myeloid leukemia and gastrointestinal stromal tumors. This delivery order was issued...
- This $5,624.62 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 22, 2024. The contract is for the supply of Tasigna 150 mg capsules to support federal healthcare requirements, with a performance period ending on September 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- This is a $6,007.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TASIGNA 150 MG CAPSULE 28S. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,249.24 to Amerisourcebergen Drug Corporation for the supply of 28 packages containing 200 mg capsules of Tasigna, a pharmaceutical product used to treat certain types of leukemia. The order is to be fulfilled by Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with performance required between August 2nd and August 23rd, 2023. Pricing for this firm fixed-price order was established at the time of award. As the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Tasigna 150 mg capsules in 28-count packages, with a ceiling value of $11,638.02 and a period of performance through March 26, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,015.80, is for the delivery of the prescription medication Tasigna 200 mg capsules. The contract is not set aside and is a firm fixed-price delivery order. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $11,249.24 contract is for the supply of the prescription drug Tasigna 150 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with a firm fixed price of $11,638.02 and a completion date of March 25, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply TASIGNA 150 MG CAPSULE 28S. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tasigna 150 mg capsules, a medication used to treat certain types of cancer. The contract has a total ceiling value of $6,007.90 and is a firm fixed-price delivery order, with a period of performance through May 20, 2025. The contract is not designated as a set-aside....
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3GDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tasigna is a specialized oncology medication used in the treatment of chronic myeloid leukemia, reflecting the Defense Logistics Agency's ongoing procurement of critical pharmaceutical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor contract running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a diverse portfolio of medications and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. The parent indefinite delivery contract demonstrates the contractor's capacity to fulfill complex, global pharmaceutical support requirements for military healthcare programs, with this specific delivery order representing a routine fulfillment under that broader vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/23/25 |